These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22489805)

  • 1. Natural polypill Xuezhikang: its clinical benefit and potential multicomponent synergistic mechanisms of action in cardiovascular disease and other chronic conditions.
    Feng Y; Xu H; Chen K
    J Altern Complement Med; 2012 Apr; 18(4):318-28. PubMed ID: 22489805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Clin Pharmacol; 2009 Aug; 49(8):947-56. PubMed ID: 19602720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin alternatives or just placebo: an objective review of omega-3, red yeast rice and garlic in cardiovascular therapeutics.
    Ong HT; Cheah JS
    Chin Med J (Engl); 2008 Aug; 121(16):1588-94. PubMed ID: 18982874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.
    Lu Z; Kou W; Du B; Wu Y; Zhao S; Brusco OA; Morgan JM; Capuzzi DM; ; Li S
    Am J Cardiol; 2008 Jun; 101(12):1689-93. PubMed ID: 18549841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    Clin Exp Hypertens; 2010; 32(8):491-8. PubMed ID: 21091365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS).
    Zhao SP; Lu ZL; Du BM; Chen Z; Wu YF; Yu XH; Zhao YC; Liu L; Ye HJ; Wu ZH;
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):81-4. PubMed ID: 17312447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study.
    Ye P; Lu ZL; Du BM; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Am Geriatr Soc; 2007 Jul; 55(7):1015-22. PubMed ID: 17608873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chinese expert consensus on the use of Xuezhikang (2017 revised edition)].
    ;
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):97-100. PubMed ID: 29397593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients.
    Huang CF; Li TC; Lin CC; Liu CS; Shih HC; Lai MM
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):438-40. PubMed ID: 17568245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xuezhikang, extract of red yeast rice, inhibited tissue factor and hypercoagulable state through suppressing nicotinamide adenine dinucleotide phosphate oxidase and extracellular signal-regulated kinase activation.
    Li P; Yang Y; Liu M
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):307-18. PubMed ID: 21697731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders.
    Yang CW; Mousa SA
    Complement Ther Med; 2012 Dec; 20(6):466-74. PubMed ID: 23131380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina.
    Li JJ; Hu SS; Fang CH; Hui RT; Miao LF; Yang YJ; Gao RL
    Clin Chim Acta; 2005 Feb; 352(1-2):217-24. PubMed ID: 15653117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese red yeast rice versus lovastatin effects on prostate cancer cells with and without androgen receptor overexpression.
    Hong MY; Seeram NP; Zhang Y; Heber D
    J Med Food; 2008 Dec; 11(4):657-66. PubMed ID: 19053857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracts of Monascusus purpureus beyond statins--profile of efficacy and safety of the use of extracts of Monascus purpureus.
    Bianchi A
    Chin J Integr Med; 2005 Dec; 11(4):309-13. PubMed ID: 16417786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential protective effects of red yeast rice in endothelial function against atherosclerotic cardiovascular disease.
    Feng SJ; Tang ZH; Wang Y; Tang XY; Li TH; Tang W; Kuang ZM
    Chin J Nat Med; 2019 Jan; 17(1):50-58. PubMed ID: 30704624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension.
    Ye P; Wu CE; Sheng L; Li H
    J Altern Complement Med; 2009 Jul; 15(7):719-25. PubMed ID: 19552598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red yeast rice for the treatment of dyslipidemia.
    Burke FM
    Curr Atheroscler Rep; 2015 Apr; 17(4):495. PubMed ID: 25728312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Bolli R; Chen Z; Wu YF; Yu XH; Zhao YC
    Int J Cardiol; 2012 Feb; 154(3):362-5. PubMed ID: 22133469
    [No Abstract]   [Full Text] [Related]  

  • 19. Red Yeast Rice Plus Berberine: Practical Strategy for Promoting Vascular and Metabolic Health.
    McCarty MF; O'Keefe JH; DiNicolantonio JJ
    Altern Ther Health Med; 2015; 21 Suppl 2():40-5. PubMed ID: 26308759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.